New paper from our lab on Mnk kinases and Syngap1 in Brain journal
Chalkiadaki et al. describe a novel link between Mnk1/2 kinases and the autism risk gene SYNGAP1.
Using mouse models, synaptic ribosome profiling and phosphoproteomics we further characterise the Mnk1/2 translatome and phosphoproteome. Importantly, Mnk1 inhibitors emerge as a potential novel therapeutic avenue for Syngap1 happloinsufficiency.
![](https://static.wixstatic.com/media/04a562_055c6277b9c24641aad6b0b281eff980~mv2.jpg/v1/fill/w_147,h_126,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/04a562_055c6277b9c24641aad6b0b281eff980~mv2.jpg)